חוב לטווח קצר להון Alkermes plc (ALKS)

The market price visualization for Alkermes plc (ALKS) on GURU.Markets demonstrates the asset's dynamics, with a value of 0.00. The business relies on exclusive rights to mental health therapies, which allows the company to maintain pricing power for its medications. Manufacturing capacities in America and Europe, along with the legal immunity of the Irish subsidiary, guarantee operational stability. Complex injection patents and strict FDA oversight ensure a high barrier to entry.

Alkermes plc (ALKS) innovative drug delivery systems ensure a stable cash flow due to inelastic demand, which is reflected in the current ratio of short-term loans to equity. This ratio measures the proportion of liabilities maturing within one year relative to equity, allowing for an assessment of liquidity risk and the stability of the asset's financing structure during periods of high debt load.